50 Participants Needed

Digital Cognitive Rehabilitation for Sickle Cell Disease

(ALL IN Trial)

SH
SR
Overseen BySara Ropeta, BS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Children's National Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you recently started or changed the dose of a stimulant medication for attention problems, you might not be eligible to participate.

What data supports the effectiveness of the treatment Cogmed+ for cognitive rehabilitation in sickle cell disease?

Research on Cogmed, a computerized cognitive training program, shows it can help improve attention, working memory, and processing speed in children with brain injuries and cancer-related cognitive issues. This suggests it might also be beneficial for cognitive challenges in sickle cell disease.12345

Is digital cognitive rehabilitation, like Cogmed+, safe for humans?

The research does not provide specific safety data for digital cognitive rehabilitation like Cogmed+ in humans, but it has been evaluated for feasibility and efficacy in children with sickle cell disease.678910

How is the treatment Cogmed+ different from other treatments for sickle cell disease?

Cogmed+ is a digital cognitive rehabilitation treatment that uses computer-based exercises to improve cognitive function, which is different from traditional treatments for sickle cell disease that focus on managing pain and preventing complications. This approach is unique because it targets cognitive impairments that can occur in sickle cell patients, offering a novel way to enhance their quality of life.311121314

What is the purpose of this trial?

This is a single site nonrandomized pilot clinical trial of the feasibility, acceptability, and efficacy of a combination treatment involving digital Cogmed working memory skills training, social support components, and memory strategy training to improve adherence to Cogmed in youth with sickle cell disease ages 7-16 years.

Research Team

SH

Steven Hardy, PhD

Principal Investigator

Children's National Research Institute

Eligibility Criteria

This trial is for young people aged 7-16 with sickle cell disease who have working memory challenges. They must be able to use a computer and speak English well, without recent changes in attention disorder medication or mental health conditions that would interfere with the study.

Inclusion Criteria

I have been diagnosed with sickle cell disease.
Patients will only enter the treatment phase if they score >1 SD below the normative mean on at least one standardized working memory assessment (i.e., Digit Span or Spatial Span subtests) or demonstrate a relative weakness in working memory (>1 SD below the estimated IQ)
I am between 7 and 16 years old.

Exclusion Criteria

Motor, visual, or auditory impairment that prevents computer use
History of photosensitive seizures
I have a mental health condition that needs treatment before I can join the cognitive training.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants engage in Cogmed+ program, including digital cognitive rehabilitation and memory strategy training, with weekly videoconference coaching

5-8 weeks
Weekly videoconference calls

Follow-up

Participants are monitored for adherence and effectiveness of the Cogmed+ program

4 weeks

Treatment Details

Interventions

  • Cogmed+
Trial Overview The trial tests a digital program called Cogmed combined with social support and memory strategies to see if it helps improve working memory skills in youth with sickle cell disease. It's not randomized; all participants will receive this combination treatment.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Cogmed+Experimental Treatment1 Intervention
Home-based digital cognitive rehabilitation and memory strategy training targeting working memory functioning.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's National Research Institute

Lead Sponsor

Trials
227
Recruited
258,000+

Findings from Research

A pilot study involving 23 pediatric cancer survivors aged 7-19 demonstrated that a home-based computerized cognitive rehabilitation program can be effectively implemented, with an 83% compliance rate.
Participants showed significant improvements in processing speed, cognitive flexibility, and memory skills, along with increased activation in the pre-frontal cortex, indicating the program's potential efficacy in enhancing cognitive function in children recovering from cancer.
A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury.Kesler, SR., Lacayo, NJ., Jo, B.[2022]
The study involved 68 survivors of pediatric brain tumors and acute lymphoblastic leukemia, who were either given the Cogmed cognitive intervention or placed on a waitlist, showing that adherence to the program was consistent across different coaches.
While some aspects of participant satisfaction and cognitive outcomes were similar, the influence of different coaching styles on these results suggests that further research is needed to standardize coaching in computerized interventions.
Disseminability of computerized cognitive training: Performance across coaches.Fournier-Goodnight, AS., Ashford, JM., Clark, KN., et al.[2020]
In a study involving 300 children (150 severe malaria survivors and 150 non-malaria children), a limited version of computerized cognitive rehabilitation training (CCRT) significantly improved attention and memory outcomes in malaria survivors compared to passive controls, suggesting that focused practice may be more effective than more complex training.
Non-malaria children showed fewer cognitive benefits from CCRT, but those receiving the full CCRT had lasting improvements in planning and reasoning skills, indicating that the intensity and structure of cognitive training can influence long-term outcomes.
Neuropsychological benefits of computerized cognitive rehabilitation training in Ugandan children surviving severe malaria: A randomized controlled trial.Boivin, MJ., Nakasujja, N., Sikorskii, A., et al.[2023]

References

A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury. [2022]
Disseminability of computerized cognitive training: Performance across coaches. [2020]
Neuropsychological benefits of computerized cognitive rehabilitation training in Ugandan children surviving severe malaria: A randomized controlled trial. [2023]
Does cognitive impairment affect rehabilitation outcome? [2021]
[Development of an integrative cognitive rehabilitation program for brain injured patients in the post-acute stage]. [2019]
Feasibility of Home-Based Computerized Working Memory Training With Children and Adolescents With Sickle Cell Disease. [2018]
Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. [2022]
A Randomized Controlled Trial of Working Memory Training in Pediatric Sickle Cell Disease. [2021]
Transition planning for youth with sickle cell disease: embedding neuropsychological assessment into comprehensive care. [2010]
Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease. [2023]
Computer-based cognitive rehabilitation program GRADIOR for mild dementia and mild cognitive impairment: new features. [2023]
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis. [2022]
Computerized Cognitive Rehabilitation Training for Ugandan Seniors Living with HIV: A Validation Study. [2021]
Computer-based cognitive rehabilitation: the CoRe system. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security